Revvity Inc. (RVTY) - Total Liabilities
Based on the latest financial reports, Revvity Inc. (RVTY) has total liabilities worth $4.81 Billion USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Revvity Inc. liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Revvity Inc. - Total Liabilities Trend (1985–2025)
This chart illustrates how Revvity Inc.'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Revvity Inc. asset portfolio.
Revvity Inc. Competitors by Total Liabilities
The table below lists competitors of Revvity Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
TELE2 AB UNSP.ADR/1/2 B
F:NCY
|
Germany | €44.72 Billion |
|
Sociedad Quimica y Minera de Chile SA ADR B
NYSE:SQM
|
USA | $6.19 Billion |
|
CARLSBERG B DK20 ADR 1/5
F:CBGC
|
Germany | €123.28 Billion |
|
Sonova H Ag
SW:SOON
|
Switzerland | CHF2.99 Billion |
|
Raytron Technology Co Ltd
SHG:688002
|
China | CN¥4.24 Billion |
|
NIPPON YUSEN K.K.SP.DR1/5
F:NYK
|
Germany | €1.49 Trillion |
|
McCormick & Company Incorporated
NYSE:MKC
|
USA | $8.90 Billion |
|
Exelixis Inc
NASDAQ:EXEL
|
USA | $683.10 Million |
Liability Composition Analysis (1985–2025)
This chart breaks down Revvity Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See RVTY equity financing ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.72 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.67 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.40 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Revvity Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Revvity Inc. (1985–2025)
The table below shows the annual total liabilities of Revvity Inc. from 1985 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $4.92 Billion | +4.07% |
| 2024-12-31 | $4.73 Billion | -16.98% |
| 2023-12-31 | $5.69 Billion | -15.64% |
| 2022-12-31 | $6.75 Billion | -14.15% |
| 2021-12-31 | $7.86 Billion | +86.03% |
| 2020-12-31 | $4.22 Billion | +13.43% |
| 2019-12-31 | $3.72 Billion | +9.86% |
| 2018-12-31 | $3.39 Billion | -5.51% |
| 2017-12-31 | $3.59 Billion | +69.01% |
| 2016-12-31 | $2.12 Billion | +3.27% |
| 2015-12-31 | $2.06 Billion | -1.42% |
| 2014-12-31 | $2.09 Billion | +6.83% |
| 2013-12-31 | $1.95 Billion | -0.50% |
| 2012-12-31 | $1.96 Billion | -2.56% |
| 2011-12-31 | $2.01 Billion | +56.86% |
| 2010-12-31 | $1.28 Billion | -10.25% |
| 2009-12-31 | $1.43 Billion | +4.86% |
| 2008-12-31 | $1.36 Billion | -0.74% |
| 2007-12-31 | $1.37 Billion | +47.34% |
| 2006-12-31 | $932.59 Million | -10.58% |
| 2005-12-31 | $1.04 Billion | -6.50% |
| 2004-12-31 | $1.12 Billion | -11.38% |
| 2003-12-31 | $1.26 Billion | -20.53% |
| 2002-12-31 | $1.58 Billion | -1.40% |
| 2001-12-31 | $1.61 Billion | +10.03% |
| 2000-12-31 | $1.46 Billion | +25.45% |
| 1999-12-31 | $1.16 Billion | +57.46% |
| 1998-12-31 | $739.10 Million | +46.71% |
| 1997-12-31 | $503.80 Million | +10.05% |
| 1996-12-31 | $457.80 Million | +4.76% |
| 1995-12-31 | $437.00 Million | +25.68% |
| 1994-12-31 | $347.70 Million | +19.36% |
| 1993-12-31 | $291.30 Million | +5.51% |
| 1992-12-31 | $276.10 Million | -0.40% |
| 1991-12-31 | $277.20 Million | -9.29% |
| 1990-12-31 | $305.60 Million | +3.80% |
| 1989-12-31 | $294.40 Million | +42.22% |
| 1988-12-31 | $207.00 Million | -15.20% |
| 1987-12-31 | $244.10 Million | +16.85% |
| 1986-12-31 | $208.90 Million | -7.73% |
| 1985-12-31 | $226.40 Million | -- |
About Revvity Inc.
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectio… Read more